Literature DB >> 31602376

Hepatocellular Carcinoma of Fibrolamellar Type in an Adolescent: Case Report and Literature Review.

Javier Santiago-Reynoso1, Karina Senyase Zamaripa-Martínez1, Juan Manuel Dorantes-Loya1, Guillermo J Gaytán-Fernández1,2, Evelia Apolinar-Jiménez1, Francisco Paz-Gómez3, Felipe Farias-Serratos1, María Maldonado-Vega1.   

Abstract

We present a female patient, 13 years old, with diagnosis of hepatocellular carcinoma of fibrolamellar type, which was rapidly evolving. The fibrolamellar hepatocellular carcinoma invaded more than 80% of the hepatic parenchyma without surgical possibility or liver transplantation. Measures applied corresponded to chemotherapy of 1 cycle of cisplatin 40 mg/s/5 days + vincristine 1.5 mg/m<sup>2</sup>/day, 5-fluorouracil, doxorubicin, and dexrazoxane. The case presented aggressive evolution of hepatocellular carcinoma, which led to acute liver failure, with hyperammonemia, sepsis, pulmonary focus plus septic shock, grade III-IV encephalopathy, portal hypertension, and ascites with intra-abdominal hypertension. Death occurred due to multiple organ failure, which involved respiratory failure type KDIGO 1 and 2, acute liver failure, severe pneumonia, pericardial effusion, AKIN 2 acute kidney injury, carcinoma, and pulmonary metastasis. This type of ailment is infrequent in children and adolescents, and the first symptoms are crucial to achieve treatment possibilities.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Encephalopathy; Hepatocellular carcinoma; Hyperammonemia; Mexican children

Year:  2019        PMID: 31602376      PMCID: PMC6738251          DOI: 10.1159/000499581

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  14 in total

1.  Efficacy of Hepatitis B Vaccination among Children in Special Region of Yogyakarta, Indonesia: Evaluation of Humoral and Cellular Immunity.

Authors:  Caessar Pronocitro; Nenny Sri Mulyani; Afif Avicenna Ghufron; Yugata Halimawan Hazazi; Bambang Ardianto; Didik Setyo Heriyanto
Journal:  Kobe J Med Sci       Date:  2018-01-17

2.  Primary hepatocellular carcinoma with hepatitis B virus-DNA integration in a 4-year-old boy.

Authors:  T Tanaka; H Miyamoto; O Hino; T Kitagawa; M Koike; T Iizuka; H Sakamoto; A Ooshima
Journal:  Hum Pathol       Date:  1986-02       Impact factor: 3.466

3.  Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.

Authors:  Saurabh Sethi; Nishant Tageja; Jatinder Singh; Haitham Arabi; Maneesh Dave; Apurva Badheka; Sanjay Revankar
Journal:  Am J Med Sci       Date:  2009-12       Impact factor: 2.378

4.  A 6-year-old boy having hepatocellular carcinoma associated with hepatitis B surface antigenemia.

Authors:  T Shimoda; T Uchida; H Miyata; K Abe; H Ariga; T Shikata; Y Fujii
Journal:  Am J Clin Pathol       Date:  1980-12       Impact factor: 2.493

5.  N-Acetylcysteine Therapy in an Infant with Transaldolase Deficiency Is Well Tolerated and Associated with Normalization of Alpha Fetoprotein Levels.

Authors:  Lance H Rodan; Gerard T Berry
Journal:  JIMD Rep       Date:  2016-04-30

6.  Hepatocellular carcinoma: significance of HBV vertical transmission.

Authors:  Y Poovorawan; R Sripattanawat; A Theamboonlers; V Chongsrisawat; I Nuchprayoon
Journal:  Asian Pac J Allergy Immunol       Date:  1998 Jun-Sep       Impact factor: 2.310

Review 7.  Pediatric hepatocellular carcinoma: challenges and solutions.

Authors:  Irene Schmid; Dietrich von Schweinitz
Journal:  J Hepatocell Carcinoma       Date:  2017-01-16

8.  Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).

Authors:  Rohan Vinayak; Ruy J Cruz; Sarangarajan Ranganathan; Ravi Mohanka; George Mazariegos; Kyle Soltys; Geoff Bond; Sameh Tadros; Abhinav Humar; J Wallis Marsh; Robert R Selby; Jorge Reyes; Qing Sun; Kimberly Haberman; Rakesh Sindhi
Journal:  Liver Transpl       Date:  2017-12       Impact factor: 5.799

9.  Long-term survival after surveillance and treatment in patients with chronic viral hepatitis and hepatocellular carcinoma.

Authors:  Myron J Tong; Alexander A Rosinski; Claiborne T Huynh; Steven S Raman; David S K Lu
Journal:  Hepatol Commun       Date:  2017-06-21

10.  A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma.

Authors:  Hae Won Lee; Jeong Min Lee; Jung-Hwan Yoon; Yoon Jun Kim; Joong-Won Park; Sang-Jae Park; Seong Hoon Kim; Nam-Joon Yi; Kyung-Suk Suh
Journal:  Ann Surg Treat Res       Date:  2018-01-30       Impact factor: 1.859

View more
  1 in total

Review 1.  A framework for fibrolamellar carcinoma research and clinical trials.

Authors:  Timothy A Dinh; Alan F Utria; Kevin C Barry; Rosanna Ma; Ghassan K Abou-Alfa; John D Gordan; Elizabeth M Jaffee; John D Scott; Jessica Zucman-Rossi; Allison F O'Neill; Mark E Furth; Praveen Sethupathy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-21       Impact factor: 73.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.